BOSTON, Oct. 15 /PRNewswire/ -- The Liver Meeting is the premier meeting in the science and practice of hepatology, including the latest findings on new drugs, novel treatments, and the results from pilot and multicenter studies.
Approximately 10 percent of Americans have some form of liver disease, and the diseases strike disproportionately among certain populations but mostly regardless of lifestyle choices. There are now numerous treatments for both hepatitis B and C, whereas liver cancer is one of the few cancers growing in incidence.
An AASLD President’s press conference highlighting key abstracts and issues presented at the Liver Meeting is scheduled for Saturday, November 3 at 4:00 p.m.
The approximately 1500 abstracts to be presented will be available to members of the press at our Web site (www.aasld.org), including almost 200 abstracts that will be presented in oral sessions.
Please contact AASLD at 703-299-9766 for information about the above presentations, or to receive any additional information about The Liver Meeting -- or visit our Web site at www.aasld.org.
This release was issued through The Xpress Press News Service, merging e-mail and satellite distribution technologies to reach business analysts and media outlets worldwide. For more information, visit http://www.XpressPress.com.
CONTACT: Gregory Bologna, gbologna@aasld.org, or Ann Tracy,
atracy@aasld.org, of American Association for the Study of Liver Diseases,
+1-703-299-9766
Web site: http://www.aasld.org/
